| Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan (NCT06504719) | Hellenic Cooperative Oncology Group | 2023-01-01 |
| Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer (NCT05372081) | Hellenic Cooperative Oncology Group | 2022-03-23 |
| Real-world Data in Patients With Breast Cancer Treated With Abemaciclib (NCT04985058) | Hellenic Cooperative Oncology Group | 2021-10-06 |
| Head and Neck cancERs International cOviD-19 collabOraTion (NCT04632173) | Hellenic Cooperative Oncology Group | 2021-05-03 |
| Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer (NCT05761977) | Hellenic Cooperative Oncology Group | 2021-03-31 |
| Responses to COVID-19 Vaccination in Patients With Cancer (NCT04745377) | Hellenic Cooperative Oncology Group | 2021-01-12 |
| Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease (NCT04805099) | Hellenic Cooperative Oncology Group | 2020-11-01 |
| Molecular Profiling in Prostate Cancer (NCT04983628) | Hellenic Cooperative Oncology Group | 2020-10-01 |
| Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer (NCT05127382) | Hellenic Cooperative Oncology Group | 2020-02-01 |
| Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer (NCT04724031) | Hellenic Cooperative Oncology Group | 2019-11-01 |
| RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma (NCT03745430) | Hellenic Cooperative Oncology Group | 2019-01-29 |
| Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy (NCT04133207) | Hellenic Cooperative Oncology Group | 2019-01-01 |
| Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer (NCT03568097) | Hellenic Cooperative Oncology Group | 2018-09-16 |
| Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer (NCT03311750) | Hellenic Cooperative Oncology Group | 2018-03-26 |
| Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer (NCT04752865) | Hellenic Cooperative Oncology Group | 2018-02-09 |
| Tumor Molecular Profiling in Patients With Prostate Cancer (NCT05573789) | Hellenic Cooperative Oncology Group | 2018-01-01 |